Antihypertensive properties of a traditional Chinese medicine GAO-ZI-YAO in elderly spontaneous hypertensive rats
Autor: | Hui Zhang, Guo-Xing Zhang, Jing-Wei Chen, Zi-Zhang Wang, Meng-Xiao Han, Bin Dai |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Vascular Endothelial Growth Factor A 0301 basic medicine Nitric oxide (NO) medicine.medical_specialty Anti-Inflammatory Agents Blood Pressure Inflammation RM1-950 Nitric Oxide Angiotensin II (Ang II) Nitric oxide 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Irbesartan GAO-ZI-YAO Rats Inbred SHR Internal medicine medicine Animals Medicine Chinese Traditional Antihypertensive Agents Pharmacology Endothelin-1 business.industry Angiotensin II Interleukin General Medicine Rats Vascular endothelial growth factor 030104 developmental biology Blood pressure Endocrinology chemistry 030220 oncology & carcinogenesis Hypertension Cytokines Tumor necrosis factor alpha Therapeutics. Pharmacology medicine.symptom business Spontaneous hypertensive rats (SHR) Drugs Chinese Herbal medicine.drug |
Zdroj: | Biomedicine & Pharmacotherapy, Vol 131, Iss, Pp 110739-(2020) |
ISSN: | 0753-3322 |
DOI: | 10.1016/j.biopha.2020.110739 |
Popis: | Aim The present study aims to investigate the antihypertensive effect and the underlying mechanism of GAO-ZI-YAO, one of the traditional Chinese medicines, in elderly spontaneous hypertensive rats (SHR). Methods 12-month-old male SHRs were randomly divided into five groups on the basis of treatment with different doses of GAO-ZI-YAO or angiotensin II receptor-1 blocker (ARB, Irbesartan) for four weeks. Systolic blood pressure (SBP), and serum levels of nitric oxide (NO), endothelin-1 (ET-1), angiotensin II (Ang II), vascular endothelial growth factor (VEGF), interleukin (IL)-1β, IL-2, IL-6, and tumor necrotic factor (TNF)-α were measured. The pathological changes of ventricular muscle and thoracic aorta were observed by hematoxylin-eosin staining (H&E). Results GAO-ZI-YAO treatment reduced SBP in a dose-dependent manner accompanied by the inhibition of the development of cardiovascular remodeling. Although GAO-ZI-YAO treatment markedly increased serum levels of NO and suppressed serum levels of Ang II, this medicine did not affect the serum levels of ET-1 and VEGF. In addition, GAO-ZI-YAO also inhibited inflammatory response parameters (inflammatory cell infiltration in cardiac tissues and serum levels of IL-1β, IL-2, IL-6, and TNF-α) in a dose-dependent manner. Conclusion GAO-ZI-YAO exerts antihypertensive and anti-cardiovascular-remodeling effects in elderly SHR, which may be through regulation of NO, Ang II production, and inflammation. |
Databáze: | OpenAIRE |
Externí odkaz: |